ERK1/2 is positioned upstream of the inflammatory pathway in cisplatin-AKI, and treatment with a MEK (MAPK/ERK kinase) inhibitor, UO126, suppresses cisplatin-induced renal inflammation and kidney cell apoptosis in mice [55, 56]. The gene discussed is MAP2K7; the disease is acute kidney injury.